Chemomab Therapeutics: Q2 Earnings Insights
Chemomab Therapeutics: Q2 Earnings Insights
Chemomab Therapeutics (NASDAQ:CMMB) reported its Q2 earnings results on Friday, August 12, 2022 at 06:00 AM.
Chemomab治療學納斯達克(Sequoia Capital：CMMB)於2022年8月12日(星期五)上午06：00公佈第二季度收益業績。
Here's what investors need to know about the announcement.
以下是投資者需要知道的關於這一聲明的信息。
Earnings
收益
Chemomab Therapeutics missed estimated earnings by 116.0%, reporting an EPS of $-0.54 versus an estimate of $-0.25.
Chemomab治療公司的預期收益低於預期的116.0%，每股收益為-0.54美元，而預期為-0.25美元。
Revenue was down $0 from the same period last year.
營收比去年同期下降了0美元。
Past Earnings Performance
過去的盈利表現
Last quarter the company beat on EPS by $0.22 which was followed by a 8.14% increase in the share price the next day.
上個季度，該公司每股收益高出0.22美元，第二天股價上漲了8.14%。
To track all earnings releases for Chemomab Therapeutics visit their earnings calendar here.
要跟蹤Chemomab治療公司的所有收益發布，請訪問此處的收益日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閲。